KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulgent Genetics (FLGT) Capital Expenditures (2016 - 2025)

Fulgent Genetics (FLGT) has disclosed Capital Expenditures for 11 consecutive years, with $5.0 million as the latest value for Q4 2025.

  • Quarterly Capital Expenditures rose 31.82% to $5.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $22.6 million through Dec 2025, down 44.01% year-over-year, with the annual reading at $22.6 million for FY2025, 44.01% down from the prior year.
  • Capital Expenditures hit $5.0 million in Q4 2025 for Fulgent Genetics, down from $15.0 million in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $19.5 million in Q3 2024 to a low of -$2.1 million in Q2 2025.
  • Historically, Capital Expenditures has averaged $6.4 million across 5 years, with a median of $4.8 million in 2022.
  • Biggest five-year swings in Capital Expenditures: soared 1343.72% in 2021 and later tumbled 116.51% in 2025.
  • Year by year, Capital Expenditures stood at $6.0 million in 2021, then fell by 21.08% to $4.7 million in 2022, then crashed by 34.22% to $3.1 million in 2023, then rose by 21.64% to $3.8 million in 2024, then soared by 31.82% to $5.0 million in 2025.
  • Business Quant data shows Capital Expenditures for FLGT at $5.0 million in Q4 2025, $15.0 million in Q3 2025, and -$2.1 million in Q2 2025.